PHRI researchers will share insights and findings on stroke prevention and treatment, genetic risk and care strategies at the International Stroke Conference (ISC) 2026, set for February 4-6 in New Orleans.
- Mike Sharma, senior scientist
Primary results of OCEANIC-STROKE:
Factor XIa Inhibition with Asundexian in Acute Non-Cardioembolic Stroke or High-Risk Transient Ischemic Attack. - Raed Joundi, scientist
Novel clinical risk prediction tool for dementia after transient ischemic attack and stroke. - Guillaume Paré, senior scientist
Applying Polygenic Risk Scores in Stroke Management: Guiding Aspirin and Statin Therapy - Kanjana Perera, scientist
- Striking the Balance: Managing Antithrombotic Therapy in Acute and Subacute ICAD-LVO Cases.
- ESUS Definition & What Is a Sufficient Work-Up?
- Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease: CATIS-ICAS.
- Ashkan Shoamanesh, senior scientist
- Qualifying Ischemic Stroke Subtypes and Response to Asundexian: Prespecified Secondary Analysis of the OCEANIC-STROKE Trial.
- Individual Participant Data Meta-Analysis of Randomized Trials of Direct Oral Anticoagulants Compared with Aspirin in Patients with Embolic Strokes of Undetermined Source.
